These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16336251)

  • 41. New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone.
    Edwards JP; West SJ; Pooley CL; Marschke KB; Farmer LJ; Jones TK
    Bioorg Med Chem Lett; 1998 Apr; 8(7):745-50. PubMed ID: 9871534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
    Furr BJ
    Horm Res; 1989; 32 Suppl 1():69-76. PubMed ID: 2533159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiandrogens prevent stable DNA-binding of the androgen receptor.
    Farla P; Hersmus R; Trapman J; Houtsmuller AB
    J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor.
    Azhagiya Singam ER; Tachachartvanich P; La Merrill MA; Smith MT; Durkin KA
    J Phys Chem B; 2019 Sep; 123(36):7657-7666. PubMed ID: 31431014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of cyproterone acetate and flutamide on blood calcium and bone structure].
    Manso Rodríguez G; Gutiérrez Cecchini B; Sala Blanco J; Hidalgo Balsera A
    Arch Esp Urol; 1986 Oct; 39(8):534-8. PubMed ID: 2950829
    [No Abstract]   [Full Text] [Related]  

  • 46. Discovery of nonsteroidal androgens.
    Dalton JT; Mukherjee A; Zhu Z; Kirkovsky L; Miller DD
    Biochem Biophys Res Commun; 1998 Mar; 244(1):1-4. PubMed ID: 9514878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.
    Dotzlaw H; Papaioannou M; Moehren U; Claessens F; Baniahmad A
    Mol Cell Endocrinol; 2003 Dec; 213(1):79-85. PubMed ID: 15062576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ligand-dependent aggregation of polyglutamine-expanded androgen receptor in neuronal cells.
    Darrington RS; Butler R; Leigh PN; McPhaul MJ; Gallo JM
    Neuroreport; 2002 Nov; 13(16):2117-20. PubMed ID: 12438937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter.
    List HJ; Smith CL; Martinez E; Harris VK; Danielsen M; Riegel AT
    Exp Cell Res; 2000 Oct; 260(1):160-5. PubMed ID: 11010820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
    Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of mutant androgen receptors by flutamide.
    Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
    Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of two non-steroidal antiandrogens on testicular function in prepubertal rats.
    Rulli SB; Gonzalez-Calvar SI; Campo S; Calandra RS
    J Androl; 1995; 16(3):225-32. PubMed ID: 7559155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
    Akakura K; Furuya Y; Ito H
    Nihon Rinsho; 1998 Aug; 56(8):2124-8. PubMed ID: 9750520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis.
    Lenie S; Smitz J
    Biol Reprod; 2009 Apr; 80(4):685-95. PubMed ID: 19074005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.
    Szelei J; Jimenez J; Soto AM; Luizzi MF; Sonnenschein C
    Endocrinology; 1997 Apr; 138(4):1406-12. PubMed ID: 9075695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains.
    Wong CI; Zhou ZX; Sar M; Wilson EM
    J Biol Chem; 1993 Sep; 268(25):19004-12. PubMed ID: 8360187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The pharmacologic profile of flutamide].
    Racca S; Di Carlo F
    G Ital Chemioter; 1985; 32(1):7-11. PubMed ID: 2937678
    [No Abstract]   [Full Text] [Related]  

  • 58. Androgen ablation induces tenascin expression in the rat prostate.
    Vollmer G; Michna H; Ebert K; Knuppen R
    Prostate; 1994 Aug; 25(2):81-90. PubMed ID: 7518598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects.
    Szafran AT; Szwarc M; Marcelli M; Mancini MA
    PLoS One; 2008; 3(11):e3605. PubMed ID: 18978937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.